Literature DB >> 26416129

Intubation of the Neurologically Injured Patient.

Joshua Bucher1, Alex Koyfman2.   

Abstract

BACKGROUND: Intubation of the neurologically injured patient is a critical procedure that must be done in a manner to prevent further neurologic injury. Although many different medications and techniques have been used to meet specific needs, there is little to no evidence to support many claims.
OBJECTIVE: To review the literature regarding important topics relating to intubating patients with neurologic injury. DISCUSSION: Airway management requires ideal preoxygenation and airway maneuvers to minimize manipulation of the larynx and to maximize first-pass success. There is no evidence that lidocaine pretreatment decreases intracerebral pressure (ICP). Fentanyl can be used to help blunt the hemodynamic response to intubation. Esmolol is another medication that can blunt the hemodynamic response. Ketamine can be used and is possibly the ideal agent, having a neutral hemodynamic profile. A prefasciculation dose for neuromuscular blockade has not been shown to have any effect on ICP.
CONCLUSIONS: Ideal intubation conditions should be obtained through the use of airway manipulation techniques and appropriate medication choice for rapid sequence intubation in patients who are neurologically injured.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  airway management; intracerebral hemorrhage; neurologically injured patients; rapid sequence intubation; traumatic brain injury

Mesh:

Substances:

Year:  2015        PMID: 26416129     DOI: 10.1016/j.jemermed.2015.06.078

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  1 in total

1.  Effect of sedative agent selection on morbidity, mortality and length of stay in patients with increase in intracranial pressure.

Authors:  Brian G Cornelius; Elizabeth Webb; Angela Cornelius; Kenneth W G Smith; Srdan Ristic; Jay Jain; Urska Cvek; Marjan Trutschl
Journal:  World J Emerg Med       Date:  2018
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.